BABA vs BBIO · P/E 20, rev $137.30B vs rev $221.9M
Alibaba Group Holding Ltd (BABA) versus BridgeBio Pharma Inc (BBIO) — a side-by-side from cached financials, not a winner call.
Alibaba Group Holding Ltd (BABA) is a internet retail company listed on US.
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
Latest reported BABA revenue for 2025-03-31 was $137.30B. Net income was $17.93B. Revenue was up 5.3% from 2024-03-31 to 2025-03-31. BABA currently screens at market cap $305.19B and trailing P/E 19.6.
Latest reported BBIO revenue for 2024-12-31 was $221.9M. Net income was -$543.3M. Revenue was up 2285.3% from 2023-12-31 to 2024-12-31. BBIO currently screens at market cap $13.24B.
BABA currently screens at market cap $305.19B and trailing P/E 19.6. BBIO currently screens at market cap $13.24B.
Not investment advice. Open the BABA and BBIO stock pages for the full models.
Not investment advice.